• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用动态对比增强(DCE)-MRI药代动力学参数的K均值聚类预测膀胱癌的化疗反应

Prediction of chemotherapeutic response in bladder cancer using K-means clustering of dynamic contrast-enhanced (DCE)-MRI pharmacokinetic parameters.

作者信息

Nguyen Huyen T, Jia Guang, Shah Zarine K, Pohar Kamal, Mortazavi Amir, Zynger Debra L, Wei Lai, Yang Xiangyu, Clark Daniel, Knopp Michael V

机构信息

Wright Center of Innovation in Biomedical Imaging, Department of Radiology, Ohio State University, Columbus, Ohio, USA.

出版信息

J Magn Reson Imaging. 2015 May;41(5):1374-82. doi: 10.1002/jmri.24663. Epub 2014 Jun 19.

DOI:10.1002/jmri.24663
PMID:24943272
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4298475/
Abstract

PURPOSE

To apply k-means clustering of two pharmacokinetic parameters derived from 3T dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to predict the chemotherapeutic response in bladder cancer at the mid-cycle timepoint.

MATERIALS AND METHODS

With the predetermined number of three clusters, k-means clustering was performed on nondimensionalized Amp and kep estimates of each bladder tumor. Three cluster volume fractions (VFs) were calculated for each tumor at baseline and mid-cycle. The changes of three cluster VFs from baseline to mid-cycle were correlated with the tumor's chemotherapeutic response. Receiver-operating-characteristics curve analysis was used to evaluate the performance of each cluster VF change as a biomarker of chemotherapeutic response in bladder cancer.

RESULTS

The k-means clustering partitioned each bladder tumor into cluster 1 (low kep and low Amp), cluster 2 (low kep and high Amp), cluster 3 (high kep and low Amp). The changes of all three cluster VFs were found to be associated with bladder tumor response to chemotherapy. The VF change of cluster 2 presented with the highest area-under-the-curve value (0.96) and the highest sensitivity/specificity/accuracy (96%/100%/97%) with a selected cutoff value.

CONCLUSION

The k-means clustering of the two DCE-MRI pharmacokinetic parameters can characterize the complex microcirculatory changes within a bladder tumor to enable early prediction of the tumor's chemotherapeutic response.

摘要

目的

应用基于3T动态对比增强磁共振成像(DCE-MRI)得出的两个药代动力学参数进行k均值聚类,以预测膀胱癌在治疗周期中期的化疗反应。

材料与方法

设定聚类数为3,对每个膀胱肿瘤的无量纲化Amp和kep估计值进行k均值聚类。在基线期和治疗周期中期计算每个肿瘤的三个聚类体积分数(VF)。从基线期到治疗周期中期三个聚类VF的变化与肿瘤的化疗反应相关。采用受试者工作特征曲线分析评估每个聚类VF变化作为膀胱癌化疗反应生物标志物的性能。

结果

k均值聚类将每个膀胱肿瘤分为1类(低kep和低Amp)、2类(低kep和高Amp)、3类(高kep和低Amp)。发现所有三个聚类VF的变化均与膀胱肿瘤对化疗的反应相关。在选定的临界值下,2类的VF变化呈现出最高的曲线下面积值(0.96)和最高的灵敏度/特异性/准确率(96%/100%/97%)。

结论

对两个DCE-MRI药代动力学参数进行k均值聚类可以表征膀胱肿瘤内复杂的微循环变化,从而能够早期预测肿瘤的化疗反应。

相似文献

1
Prediction of chemotherapeutic response in bladder cancer using K-means clustering of dynamic contrast-enhanced (DCE)-MRI pharmacokinetic parameters.利用动态对比增强(DCE)-MRI药代动力学参数的K均值聚类预测膀胱癌的化疗反应
J Magn Reson Imaging. 2015 May;41(5):1374-82. doi: 10.1002/jmri.24663. Epub 2014 Jun 19.
2
Optimizing MRI scan time in the computation of pharmacokinetic parameters (K(trans) ) in breast cancer diagnosis.优化 MRI 扫描时间在乳腺癌诊断中计算药代动力学参数(K(trans) )。
J Magn Reson Imaging. 2013 Sep;38(3):573-9. doi: 10.1002/jmri.24008. Epub 2013 Jan 24.
3
Improving bladder cancer imaging using 3-T functional dynamic contrast-enhanced magnetic resonance imaging.使用3-T功能动态对比增强磁共振成像改善膀胱癌成像
Invest Radiol. 2014 Jun;49(6):390-5. doi: 10.1097/RLI.0000000000000022.
4
Computer-aided diagnosis of breast DCE-MRI using pharmacokinetic model and 3-D morphology analysis.基于药代动力学模型和三维形态分析的乳腺动态对比增强磁共振成像计算机辅助诊断
Magn Reson Imaging. 2014 Apr;32(3):197-205. doi: 10.1016/j.mri.2013.12.002. Epub 2013 Dec 17.
5
Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.利用动态对比增强磁共振成像的药代动力学参数评估肝纤维化
J Magn Reson Imaging. 2016 Jul;44(1):98-104. doi: 10.1002/jmri.25132. Epub 2015 Dec 28.
6
Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation.3T 下前列腺癌 DCE-MRI 的定量药代动力学分析:两种动脉输入函数在癌症检测中的比较及数字化全层组织病理学验证
Magn Reson Imaging. 2015 Sep;33(7):886-94. doi: 10.1016/j.mri.2015.02.008. Epub 2015 Feb 14.
7
Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.前列腺优化快速动态对比增强磁共振成像:采样持续时间对药代动力学参数的影响
Invest Radiol. 2016 Feb;51(2):106-12. doi: 10.1097/RLI.0000000000000213.
8
Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.3T磁共振成像动态对比增强扫描在前列腺癌中的应用:药代动力学参数研究
AJR Am J Roentgenol. 2007 Oct;189(4):849. doi: 10.2214/AJR.06.1329.
9
A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementation.通过个体和基于队列的动脉输入函数(AIF)估计前列腺癌动态对比增强磁共振成像(DCE-MRI)参数的两种方法比较:迈向实际应用的一步。
Magn Reson Imaging. 2014 May;32(4):321-9. doi: 10.1016/j.mri.2014.01.004. Epub 2014 Jan 21.
10
Improved accuracy and precision of tracer kinetic parameters by joint fitting to variable flip angle and dynamic contrast enhanced MRI data.通过联合拟合可变翻转角和动态对比增强磁共振成像数据提高示踪剂动力学参数的准确性和精确性。
Magn Reson Med. 2016 Oct;76(4):1270-81. doi: 10.1002/mrm.26013. Epub 2015 Oct 19.

引用本文的文献

1
Quantitative assessment of bladder tissue properties using magnetic resonance fingerprinting: a pilot feasibility study in healthy volunteers.使用磁共振指纹技术对膀胱组织特性进行定量评估:一项在健康志愿者中的初步可行性研究。
Radiol Bras. 2025 May 1;58:e20240104. doi: 10.1590/0100-3984.2024.0104. eCollection 2025 Jan-Dec.
2
Differential performance of imaging modalities predicting pathological response to neoadjuvant chemotherapy in urothelial bladder cancer: a systematic review and meta-analysis.预测尿路上皮膀胱癌新辅助化疗病理反应的成像模态的差异表现:一项系统评价和荟萃分析。
Cent European J Urol. 2024;77(3):436-446. doi: 10.5173/ceju.2024.73. Epub 2024 Jun 18.
3

本文引用的文献

1
Improving bladder cancer imaging using 3-T functional dynamic contrast-enhanced magnetic resonance imaging.使用3-T功能动态对比增强磁共振成像改善膀胱癌成像
Invest Radiol. 2014 Jun;49(6):390-5. doi: 10.1097/RLI.0000000000000022.
2
Rectal cancer: assessment of response to neoadjuvant chemoradiation by dynamic contrast-enhanced MRI.直肠癌:动态对比增强 MRI 评估新辅助放化疗的反应。
J Magn Reson Imaging. 2013 Jul;38(1):119-26. doi: 10.1002/jmri.23952. Epub 2012 Nov 27.
3
Current perspectives in bladder cancer management.膀胱癌管理的当前观点。
Comparative diagnostic performance of VI-RADS based on biparametric and multiparametric MRI in predicting muscle invasion in bladder cancer.
基于双参数和多参数MRI的VI-RADS在预测膀胱癌肌肉浸润方面的比较诊断性能
BMC Med Imaging. 2025 Feb 24;25(1):60. doi: 10.1186/s12880-025-01595-3.
4
Multiparametric MRI and artificial intelligence in predicting and monitoring treatment response in bladder cancer.多参数磁共振成像与人工智能在预测和监测膀胱癌治疗反应中的应用
Insights Imaging. 2025 Jan 2;16(1):7. doi: 10.1186/s13244-024-01884-5.
5
Diagnostic accuracy and inter-reader agreement of the nacVI-RADS for bladder cancer treated with neoadjuvant chemotherapy: a prospective validation study.新辅助化疗治疗膀胱癌的nacVI-RADS诊断准确性及阅片者间一致性:一项前瞻性验证研究
Eur Radiol. 2024 Dec 31. doi: 10.1007/s00330-024-11327-w.
6
Retrospective analysis of multiparametric MRI in predicting complete pathologic response of neo-adjuvant chemotherapy in bladder cancer.回顾性分析多参数 MRI 预测膀胱癌新辅助化疗完全病理反应的价值。
BMC Med Imaging. 2024 Oct 7;24(1):268. doi: 10.1186/s12880-024-01441-y.
7
Multiparametric Characterization of the DSL-6A/C1 Pancreatic Cancer Model in Rats.大鼠DSL-6A/C1胰腺癌模型的多参数表征
Cancers (Basel). 2024 Apr 17;16(8):1535. doi: 10.3390/cancers16081535.
8
Clinical application of bladder MRI and the Vesical Imaging-Reporting and Data System.膀胱 MRI 的临床应用及 Vesical Imaging-Reporting and Data System。
Nat Rev Urol. 2024 Apr;21(4):243-251. doi: 10.1038/s41585-023-00830-2. Epub 2023 Nov 30.
9
Multiparametric MRI in Era of Artificial Intelligence for Bladder Cancer Therapies.人工智能时代用于膀胱癌治疗的多参数磁共振成像
Cancers (Basel). 2023 Nov 18;15(22):5468. doi: 10.3390/cancers15225468.
10
Biparametric magnetic resonance imaging assessment for detection of muscle-invasive bladder cancer: a systematic review and meta-analysis.双参数磁共振成像评估在膀胱癌肌层浸润检测中的应用:系统评价和荟萃分析。
Eur Radiol. 2022 Sep;32(9):6480-6492. doi: 10.1007/s00330-022-08696-5. Epub 2022 Apr 1.
Int J Clin Pract. 2013 May;67(5):435-48. doi: 10.1111/ijcp.12075. Epub 2012 Nov 9.
4
Evaluation of therapeutic response to concurrent chemoradiotherapy in patients with cervical cancer using diffusion-weighted MR imaging.采用弥散加权磁共振成像评估宫颈癌患者同步放化疗的治疗反应。
J Magn Reson Imaging. 2013 Jan;37(1):187-93. doi: 10.1002/jmri.23804. Epub 2012 Sep 27.
5
Pharmacokinetic analysis based on dynamic contrast-enhanced MRI for evaluating tumor response to preoperative therapy for oral cancer.基于动态对比增强 MRI 的药代动力学分析评估口腔癌术前治疗的肿瘤反应。
J Magn Reson Imaging. 2012 Sep;36(3):589-97. doi: 10.1002/jmri.23704. Epub 2012 May 30.
6
Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer.扩散加权磁共振成像在预测肌层浸润性膀胱癌对放化疗敏感性中的作用。
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):e21-7. doi: 10.1016/j.ijrobp.2011.11.065. Epub 2012 Mar 11.
7
Progress in personalizing chemotherapy for bladder cancer.膀胱癌个体化化疗的进展。
Adv Urol. 2012;2012:364919. doi: 10.1155/2012/364919. Epub 2012 Feb 13.
8
Comparison of 1.5 and 3.0 T for contrast-enhanced pulmonary magnetic resonance angiography.1.5T 与 3.0T 对比增强肺部磁共振血管造影的比较。
Clin Appl Thromb Hemost. 2012 Mar-Apr;18(2):134-9. doi: 10.1177/1076029611419840. Epub 2011 Oct 12.
9
Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging.预测局部进展期直肠癌新辅助放化疗的反应:3.0T 磁共振弥散加权成像。
J Magn Reson Imaging. 2012 Jan;35(1):110-6. doi: 10.1002/jmri.22749. Epub 2011 Oct 11.
10
Pharmacokinetic analysis and k-means clustering of DCEMR images for radiotherapy outcome prediction of advanced cervical cancers.基于 DCEMR 图像的药代动力学分析和 K 均值聚类在预测晚期宫颈癌放疗效果中的应用
Acta Oncol. 2011 Aug;50(6):859-65. doi: 10.3109/0284186X.2011.578586.